Biodimension
India's Non-Animal Methods leader

Human tissue,
engineered to predict.

Non-animal (NAMs) testing platforms: reconstructed human tissues, patient organoids and the studies that use them.

A full-stack biofabrication platform — design, cells and biomaterials combined into functional replicas of human tissue for drug discovery, cosmetic safety, and regenerative medicine.

Recognised byDST, Govt. of IndiaDBT–BIRACHumane Society Intl.Startup India

15+

Human tissue models

200

Units / production cycle

ISO 9001:2015

Certified NAMs facility · Bengaluru

Cruelty-free
What we make

One platform, four ways to model the human body

From reconstructed skin to patient-derived tumours — pick a ready model, or have us build one to your question.

Reconstructed tissue

Skin that behaves like skin

Multilayered human epidermis and full-thickness models built from primary cells at an air-liquid interface — faithful to native barrier function.

BioDEpiBioDFTBioDVagRequest a sample →
OrgCan™ organoids

Tumours, grown true to patient

Patient-derived cancer organoids that preserve tumour architecture, microenvironment and genetics for precision oncology.

BreastColorectalMelanomaRequest a sample →
Disease models

Conditions, modelled in 3D

Acne, dandruff, psoriasis, atopic dermatitis and melanoma — engineered tissue for targeted efficacy screening.

BioDAcneBioDPsorBioDMelRequest a sample →
Primary cells

Ethically-sourced, early passage

Highly characterised keratinocytes, fibroblasts and melanocytes for your own 3D models and assays.

NHEKNHDFMelanocytesRequest a sample →
Why human-relevant

Data your regulators will recognise

Reconstructed human tissue gives you pre-market safety and efficacy claims — at higher throughput, lower cost, and zero animal or volunteer risk.

Predictivity vs. animal models — chart
  • 01

    Human-relevant by design

    3D models that mimic real physiology — superior prediction of efficacy, toxicity and ADME over animal testing.

  • 02

    Ready for the new regulations

    Aligned with the FDA Modernization Act 3.0 and EMA's shift away from animal testing — built for the future of approval.

  • 03

    Reproducible, validated science

    Standardised endpoints — qRT-PCR, ELISA, TEER, histology, SEM — for results you can stake a submission on.

  • 04

    Regulatory-aligned methods

    OECD TG 431 / 439 / 492 / 442, ISO 10993-5 and FDA/EMA frameworks supported end to end.

Proof, not promises

Trusted by the brands shaping the industry

We work with visionary companies to validate safety, ensure compliance, and eliminate reliance on animal testing.

ISO 9001:2015
Certified facility
3
Patents in pipeline
30+
Active partnerships
50+ yrs
Combined expertise
  • Unilever
  • Himalaya
  • CavinKare
  • ITC
  • Eurofins
  • Clinuvel
  • Foxtale
  • Innovist
Recognition & governance

Backed and recognised

From government bodies to global welfare organisations — and held to transparent corporate governance.

We maintain the highest standards of corporate governance and transparency. Latest filings — including the Annual Return (MGT-7A, FY 2023–24) — and our Privacy Policy are available on request.

Bring us a hard question.

From scientific claim substantiation to a bespoke disease model, our scientists work alongside your team. Tell us what you are trying to build.